Who owns Kyverna Therapeutics, Inc.?
- Ticker: KYTX
- CUSIP Number: 501976104
Tip: Access positions for across all investors
Analyze quarterly positions in Kyverna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kyverna Therapeutics stock
Who bought or sold Kyverna Therapeutics, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vida Ventures Advisors | 4.5M | $22M | 0% | Sep 2024 |
|
| Bain Capital Life Sciences Investors | 3.4M | $25M | 6% | Jun 2024 |
|
| Northpond Ventures | 3.3M | $24M | 0% | Jun 2024 |
|
| Jpmorgan Chase & Co | 2.1M | $16M | 144% | Jun 2024 |
|
| Deerfield Management Company | 2.0M | $15M | 36% | Jun 2024 |
|
| Novo A/S | 1.8M | $13M | 150% | Jun 2024 |
|
| BlackRock | 1.5M | $11M | 94% | Jun 2024 |
|
| Vanguard Group | 1.0M | $7.6M | 285% | Jun 2024 |
|
| Millennium Management | 923k | $6.9M | 33% | Jun 2024 |
|
| Insight Holdings | 913k | $6.8M | 0% | Jun 2024 |
|
| Franklin Resources | 823k | $6.2M | 79% | Jun 2024 |
|
| T. Rowe Price Associates | 670k | $5.0M | -28% | Jun 2024 |
|
| Casdin Capital | 575k | $4.3M | 283% | Jun 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 499k | $3.7M | 233% | Jun 2024 |
|
| EcoR1 Capital | 450k | $3.4M | 0% | Jun 2024 |
|
| Mbb Public Markets I | 410k | $3.1M | 100% | Jun 2024 |
|
| Geode Capital Management | 373k | $2.8M | 116% | Jun 2024 |
|
| State Street Corporation | 316k | $2.4M | 527% | Jun 2024 |
|
| Citadel Advisors | 248k | $1.9M | -53% | Jun 2024 |
|
| Sphera Funds Management | 236k | $1.8M | 100% | Jun 2024 |
|
| Artal Group | 200k | $1.5M | 0% | Jun 2024 |
|
| Affinity Asset Advisors | 200k | $1.5M | 100% | Jun 2024 |
|
| E Fund Management | 189k | $1.4M | 100% | Jun 2024 |
|
| Rock Springs Capital Management | 179k | $1.3M | 0% | Jun 2024 |
|
| Two Sigma Investments | 156k | $1.2M | 650% | Jun 2024 |
|
| Perceptive Advisors | 150k | $1.1M | 0% | Jun 2024 |
|
| Woodline Partners | 133k | $997k | -66% | Jun 2024 |
|
| Charles Schwab Investment Management | 125k | $938k | 47% | Jun 2024 |
|
| Morgan Stanley | 119k | $895k | 199% | Jun 2024 |
|
| Wells Fargo & Company | 113k | $845k | 847% | Jun 2024 |
|
| TD Asset Management | 90k | $677k | 100% | Jun 2024 |
|
| Alyeska Investment Group | 90k | $675k | 38% | Jun 2024 |
|
| XTX Topco | 83k | $625k | 100% | Jun 2024 |
|
| Jump Financial | 67k | $505k | 100% | Jun 2024 |
|
| Goldman Sachs Group | 62k | $467k | 100% | Jun 2024 |
|
| Schonfeld Strategic Advisors | 61k | $460k | 100% | Jun 2024 |
|
| Barclays | 58k | $431k | 34% | Jun 2024 |
|
| Bank of New York Mellon | 56k | $419k | 100% | Jun 2024 |
|
| Sofinnova Ventures | 48k | $359k | 378% | Jun 2024 |
|
| Qube Research & Technologies | 42k | $318k | -39% | Jun 2024 |
|
| Polar Securities | 40k | $300k | 0% | Jun 2024 |
|
| Ghisallo Capital Management | 40k | $300k | 0% | Jun 2024 |
|
| Manufacturers Life Insurance Company | 38k | $284k | 33% | Jun 2024 |
|
| Swiss National Bank | 30k | $223k | 100% | Jun 2024 |
|
| Alliancebernstein | 26k | $193k | -95% | Jun 2024 |
|
| Bank of America Corporation | 25k | $189k | 89% | Jun 2024 |
|
| Discovery Capital Management | 25k | $188k | 0% | Jun 2024 |
|
| Nuveen Asset Management | 23k | $171k | 100% | Jun 2024 |
|
| Jane Street | 22k | $165k | -41% | Jun 2024 |
|
| Teachers Retirement System Of The State Of Kentucky | 21k | $161k | 70% | Jun 2024 |
|
| Rhumbline Advisers | 20k | $150k | 100% | Jun 2024 |
|
| Alpine Partners VI | 16k | $121k | 100% | Jun 2024 |
|
| Federated Investors | 16k | $120k | 100% | Jun 2024 |
|
| California State Teachers Retirement System | 15k | $113k | 100% | Jun 2024 |
|
| New York State Common Retirement Fund | 14k | $102k | 7332% | Jun 2024 |
|
| Gagnon Securities | 12k | $91k | 100% | Jun 2024 |
|
| Creative Planning | 11k | $54k | 100% | Sep 2024 |
|
| Marshall Wace | 10k | $78k | -93% | Jun 2024 |
|
| DekaBank Deutsche Girozentrale | 7.5k | $181k | 0% | Jun 2024 |
|
| Citigroup | 5.2k | $39k | -91% | Jun 2024 |
|
| MetLife Investment Advisors | 4.7k | $35k | 100% | Jun 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.1k | $23k | 100% | Jun 2024 |
|
| Summit Investment Advisors | 1.6k | $12k | 100% | Jun 2024 |
|
| Royal Bank of Canada | 1.6k | $12k | 39500% | Jun 2024 |
|
| Bnp Paribas Arbitrage, Snc | 1.2k | $9.0k | 100% | Jun 2024 |
|
| nVerses Capital | 600.00 | $2.9k | 100% | Sep 2024 |
|
| Amalgamated Bank | 582.00 | $4.0k | 100% | Jun 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 323.00 | $2.4k | 100% | Jun 2024 |
|
| Brian McDonald | 152.00 | $1.1k | 141% | Jun 2024 |
|
| Washington Trust Advisors | 60.00 | $450.000000 | 0% | Jun 2024 |
|
| CWM | 55.00 | $0 | 100% | Sep 2024 |
|
Who sold out of Kyverna Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jennison Associates | Mar 2024 | 1.4M | $35M |
| Commodore Capital | Mar 2024 | 912k | $23M |
| Henderson Group | Mar 2024 | 607k | $15M |
| Logos Global Management | Mar 2024 | 500k | $12M |
| Cormorant Asset Management | Mar 2024 | 440k | $11M |
| Avidity Partners Management | Mar 2024 | 202k | $5.0M |
| Cutter Capital Management | Mar 2024 | 167k | $4.1M |
| LMR Partners | Mar 2024 | 105k | $2.6M |
| Blackstone Group | Mar 2024 | 100k | $2.5M |
| Squarepoint Ops | Mar 2024 | 88k | $2.2M |
| Invesco | Mar 2024 | 76k | $1.9M |
| Arrowpoint Asset Management | Mar 2024 | 70k | $1.7M |
| Point72 | Mar 2024 | 61k | $1.5M |
| Hudson Bay Capital Management | Mar 2024 | 50k | $1.2M |
| Paradigm Biocapital Advisors | Mar 2024 | 50k | $1.2M |
| Stempoint Capital | Mar 2024 | 41k | $1.0M |
| Laurion Capital Management | Mar 2024 | 38k | $932k |
| Point72 Asset Management | Mar 2024 | 21k | $519k |
| Davidson Kempner Capital Management | Mar 2024 | 20k | $495k |
| Balyasny Asset Management | Mar 2024 | 17k | $415k |
| Susquehanna International | Mar 2024 | 13k | $325k |
| Brevan Howard Capital Management | Mar 2024 | 11k | $284k |
| Point72 Asia | Mar 2024 | 10k | $252k |
| Diametric Capital | Mar 2024 | 9.3k | $231k |
| Cubist Systematic Strategies | Mar 2024 | 2.8k | $69k |
| Macquarie Group | Mar 2024 | 950.00 | $24.035000 |
| Tower Research Capital | Mar 2024 | 766.00 | $19k |
| WestEnd Capital Management | Jun 2024 | 445.00 | $3.5k |